Literature DB >> 19052706

[Pulmonary embolism].

Andreas Walther1, Bernd W Böttiger.   

Abstract

The annual incidence of pulmonary embolism (PE) in western industrial nations is about 1 to 1.5 cases per 1,000 citizens. For the prognosis of the patients it is important to consider PE early as a differential diagnosis. The clinical disorders are non-specific and varied. The most frequent clinical signs of PE are dyspnoea, tachypnoea, tachycardia and chest pain. Diagnostic algorithms are available for the diagnosis of PE. There is a cardinal difference in diagnostic procedure between clinically stable and instable patients. The criteria for stability are mainly hemodynamic values. In hemodynamically instable patients echocardiography is the most important diagnostic tool. Therapeutical goals depend on the severity of PE and include hemodynamic stabilisation, prevention of the growth of the thrombus, recanalisation of pulmonal arterial vessels, removal of hypoxemia, and prophylaxis of recurrence. Anticoagulation is the only therapy of choice in stable patient of risk classification I. Interventions like thrombolysis and embolectomy are mainly indicated in hemodynamically instable patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052706     DOI: 10.1007/s10354-008-0609-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  11 in total

Review 1.  [Acute pulmonary artery embolism].

Authors:  A Walther; B W Böttiger
Journal:  Anaesthesist       Date:  2002-05       Impact factor: 1.041

Review 2.  Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism.

Authors:  Nils Kucher; Samuel Z Goldhaber
Journal:  Circulation       Date:  2003-11-04       Impact factor: 29.690

Review 3.  Inferior vena cava filters in the management of venous thromboembolism.

Authors:  Mark A Crowther
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

4.  Use of a clinical model for safe management of patients with suspected pulmonary embolism.

Authors:  P S Wells; J S Ginsberg; D R Anderson; C Kearon; M Gent; A G Turpie; J Bormanis; J Weitz; M Chamberlain; D Bowie; D Barnes; J Hirsh
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

Review 5.  Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

Review 6.  Modern management of pulmonary embolism.

Authors:  N R Tai; A S Atwal; G Hamilton
Journal:  Br J Surg       Date:  1999-07       Impact factor: 6.939

Review 7.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Harry R Büller; Giancarlo Agnelli; Russel D Hull; Thomas M Hyers; Martin H Prins; Gary E Raskob
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism.

Authors:  Stavros Konstantinides; Annette Geibel; Manfred Olschewski; Wolfgang Kasper; Nadine Hruska; Sebastian Jäckle; Lutz Binder
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

Review 9.  Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Johann Motsch; Andreas Walther; Matthias Bock; Bernd W Böttiger
Journal:  Curr Opin Anaesthesiol       Date:  2006-02       Impact factor: 2.706

Review 10.  Pulmonary embolism in the critically ill.

Authors:  David J Carlbom; Bruce L Davidson
Journal:  Chest       Date:  2007-07       Impact factor: 9.410

View more
  2 in total

1.  Importance of risk factors for the evaluation of patients with a suspected pulmonary embolism.

Authors:  Joachim Gruettner; Tim Viergutz; Merle Bolte; Thomas Henzler; Stefan O Schoenberg; Sonja Sudarski; Paul Apfaltrer; Thomas Walter
Journal:  Exp Ther Med       Date:  2015-03-30       Impact factor: 2.447

Review 2.  The diagnosis and treatment of acute pulmonary embolism.

Authors:  Alexander Schellhaass; Andreas Walther; Stavros Konstantinides; Bernd W Böttiger
Journal:  Dtsch Arztebl Int       Date:  2010-08-30       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.